Tafalgie Therapeutics

About Tafalgie Therapeutics

The startup is focused on developing a novel protein-based analgesic derived from CNRS and IBDM research to treat neuropathic and inflammatory pain. This approach aims to provide rapid relief for patients suffering from chronic conditions such as migraines, muscle pain, and neuropathies.

What does Tafalgie Therapeutics do?

The startup is focused on developing a novel protein-based analgesic derived from CNRS and IBDM research to treat neuropathic and inflammatory pain. This approach aims to provide rapid relief for patients suffering from chronic conditions such as migraines, muscle pain, and neuropathies.

Where is Tafalgie Therapeutics located?

Tafalgie Therapeutics is based in Marseille, France.

When was Tafalgie Therapeutics founded?

Tafalgie Therapeutics was founded in 2020.

How much funding has Tafalgie Therapeutics raised?

Tafalgie Therapeutics has raised 6270000.

Location
Marseille, France
Founded
2020
Funding
6270000
Employees
15 employees

Find Investable Startups and Competitors

Search thousands of startups using natural language

Start Searching

Tafalgie Therapeutics

⚠️ AI-generated overview based on web search data – may contain errors, please verify information yourself! You can claim this account with your email domain to make edits.

Executive Summary

The startup is focused on developing a novel protein-based analgesic derived from CNRS and IBDM research to treat neuropathic and inflammatory pain. This approach aims to provide rapid relief for patients suffering from chronic conditions such as migraines, muscle pain, and neuropathies.

tafalgie.fr1K+
cb
Crunchbase
Founded 2020 – Marseille, France

Funding

$

Estimated Funding

$5M+

Team (15+)

No team information available.
Want to add first party data to your startup here or get your entry removed? You can edit it yourself by logging in with your company domain.